Skip to main content

Celldex Therapeutics, Inc.

CLDX
Exchange
Nasdaq
Industry
In Vitro & In Vivo Diagnostic Substances
SEC CIK
0000744218

No open-market purchases or sales by Celldex Therapeutics, Inc. insiders were filed in the last 90 days; 253 institutions reported holding it in 13F filings for Q2 2026, worth $3.16B in total; no superinvestor holds it.

Q1 2026 vs. Q4 2025

How the institutions holding Celldex Therapeutics, Inc. changed between Q4 2025 and Q1 2026.

All holders in Q1 2026All holders in Q4 2025

13F holders of CLDX: Q4 2025 compared with Q1 2026
MeasureQ4 2025Of which not filed for Q1 2026Q1 2026Change
Holders1873229+45
Shares73.0M4.03M72.6M+3.57M (+5.2%)
Value$1.99B$109.4M$2.31B+$428.6M (+22.7%)

3 institutions that held it in Q4 2025 haven't filed for Q1 2026 yet. Not filing isn't selling, so the changes leave them out.

New holders (59)

Institutions that held Celldex Therapeutics, Inc. at the end of Q1 2026 but not at the end of Q4 2025.

Institutions new to CLDX in Q1 2026
InstitutionSharesValue% of portfolio
Vanguard Capital Management LLC2,960,895$93.9M0.00%
Vanguard Portfolio Management LLC629,252$20.0M0.00%
Ikarian Capital, LLC461,247$14.6M2.09%
Vanguard Fiduciary Trust Co429,597$13.6M0.00%
Kennedy Capital Management, Inc.352,302$11.2M0.24%
Rosalind Advisors, Inc.330,000$10.5M4.29%
Foresite Capital Management VI LLC315,913$10.0M2.18%
Palo Alto Investors LP296,408$9.40M1.44%
Candriam Luxembourg S.C.A.278,888$8.85M0.05%
StemPoint Capital LP254,267$8.07M1.55%
Assenagon Asset Management S.A.146,525$4.65M0.01%
Boothbay Fund Management, LLC134,945$4.28M0.10%
Jane Street Group, LLC90,321$2.86M0.00%
Balyasny Asset Management LLC85,026$2.70M0.01%
Birchview Capital, LP70,095$2.22M1.27%
Y-Intercept (Hong Kong) Ltd45,192$1.43M0.03%
Cinctive Capital Management LP41,233$1.31M0.09%
Vanguard Asset Management, Ltd41,091$1.30M0.00%
SEI Investments Co38,152$1.21M0.00%
Susquehanna International Group, LLP35,948$1.14M0.00%
Tudor Investment Corp Et Al35,393$1.12M0.01%
Seven Fleet Capital Management LP29,300$929.4K0.29%
Vanguard Global Advisers, LLC26,037$825.9K0.00%
Quadrature Capital Ltd24,440$775.2K0.01%
Susquehanna Portfolio Strategies, LLC22,180$703.5K0.01%
State of New Jersey Common Pension Fund D20,439$648.3K0.00%
Virtu Financial LLC19,830$629.0K0.03%
Fred Alger Management, LLC18,454$585.4K0.00%
Vanguard Investments Australia, Ltd.14,345$455.0K0.00%
Bank of Montreal12,995$412.2K0.00%
AlphaCentric Advisors LLC12,614$400.1K0.40%
Twinbeech Capital LP11,445$363.0K0.04%
Glenmede Trust Co NA11,267$357.4K0.00%
Prudential Financial Inc10,403$330.0K0.00%
Scientech Research LLC9,502$301.4K0.25%
Amundi9,351$296.6K0.00%
Brevan Howard Capital Management LP9,255$293.6K0.00%
E Fund Management Co., Ltd.8,178$259.4K0.01%
Walleye Capital LLC8,147$258.4K0.00%
AQR Capital Management LLC7,777$246.7K0.00%
Jain Global LLC7,763$246.2K0.00%
EntryPoint Capital, LLC7,430$235.7K0.07%
Axq Capital, LP7,237$229.6K0.03%
Diversified Trust Co7,021$222.7K0.00%
Panoramic Investment Advisors, LLC6,500$206.2K0.11%
Aquatic Capital Management LLC5,130$162.7K0.00%
Advisory Services Network, LLC4,625$146.7K0.00%
Kemnay Advisory Services Inc.551$17.5K0.00%
Keating Financial Advisory Services, Inc.456$14.5K0.00%
Innovative Asset Advisors Group, LLC200$6.34K0.00%
JPL Wealth Management, LLC75$2.38K0.00%
Twin Peaks Wealth Advisors, LLC46$1.46K0.00%
Fifth Third Bancorp31$9690.00%
Assetmark, Inc21$6660.00%
Massmutual Trust Co FSB18$5710.00%
Fortitude Family Office, LLC16$5080.00%
MAI Capital Management8$2540.00%
Essential Partners LLC3$950.00%
Hughes Financial Services, LLC1$320.00%

Sold out (14)

Institutions that held Celldex Therapeutics, Inc. at the end of Q4 2025 and filed for Q1 2026 without it.

Institutions that sold out of CLDX in Q1 2026
InstitutionShares, Q4 2025Value, Q4 2025
Polar Capital Holdings Plc1,008,163$27.4M
Renaissance Technologies LLC118,488$3.22M
Argent Trust Co8,481$230.3K
Quest Partners LLC8,018$217.8K
Values First Advisors, Inc.7,728$209.9K
Kestra Advisory Services, LLC3,600$97.8K
Amalgamated Bank2,058$56.0K
Group One Trading, L.P.748$20.3K
Clear Street Markets LLC452$12.3K
Quarry LP180$4.89K
Strategic Advocates LLC130$3.44K
Bare Financial Services, Inc79$2.15K
Concord Wealth Partners8$217
Strategic Investment Solutions, Inc.5$136

Not filed for Q1 2026 yet (3)

Institutions that held Celldex Therapeutics, Inc. at the end of Q4 2025 and haven't filed a 13F for Q1 2026. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding CLDX in Q4 2025 that haven't filed for Q1 2026
InstitutionShares, Q4 2025Value, Q4 2025
Vanguard Group Inc4,027,407$109.4M
CIBC Private Wealth Group, LLC500$13.6K
Comerica Bank31$830